Owner only: item control page
Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients
Hutterer, M., Hattingen, E.
, Palm, C. , Proescholdt, M. A. and Hau, P.
(2015)
Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients.
Neuro-Oncology 17 (6), pp. 784-800.
Date of publication of this fulltext: 19 Dec 2024 07:34
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Neuro-Oncology | ||||
| Publisher: | OXFORD UNIV PRESS INC | ||||
|---|---|---|---|---|---|
| Place of Publication: | CARY | ||||
| Volume: | 17 | ||||
| Number of Issue or Book Chapter: | 6 | ||||
| Page Range: | pp. 784-800 | ||||
| Date | 2015 | ||||
| Institutions | Medicine > Lehrstuhl für Neurochirurgie Medicine > Lehrstuhl für Neurologie | ||||
| Identification Number |
| ||||
| Keywords | BEVACIZUMAB PLUS IRINOTECAN; RECURRENT MALIGNANT GLIOMA; MAGNETIC-RESONANCE-SPECTROSCOPY; PHASE-II TRIAL; APPARENT DIFFUSION-COEFFICIENT; POSITRON-EMISSION-TOMOGRAPHY; SINGLE-AGENT BEVACIZUMAB; ADC HISTOGRAM ANALYSIS; CEREBRAL BLOOD-VOLUME; F-18-FET PET; high-grade glioma; antiangiogenic treatment; MRI; PET; multimodal response assessment | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 60372 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric